Patent details

EP3364993 Title: METHODS FOR TREATING ANGELMAN SYNDROME

Basic Information

Publication number:
EP3364993
PCT Application Number:
US2016058487
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP168584431
PCT Publication Number:
WO2017070680
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHODS FOR TREATING ANGELMAN SYNDROME
French Title of Invention:
PROCÉDÉS POUR TRAITER LE SYNDROME D'ANGELMAN
German Title of Invention:
VERFAHREN ZUR BEHANDLUNG DES ANGELMAN-SYNDROMS
SPC Number:

Dates

Filing date:
24/10/2016
Grant date:
09/11/2022
EP Publication Date:
29/08/2018
PCT Publication Date:
27/04/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/11/2022
EP B1 Publication Date:
09/11/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
24/10/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
02/11/2022
 
 

Name:
Cavion, Inc.
Address:
3170 Porter Drive, Palo Alto, CA 94304, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
11/11/2022
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
MARICICH, Yuri
Address:
United States (US)

Priority

Priority Number:
201562245038 P
Priority Date:
22/10/2015
Priority Country:
United States (US)

Classification

IPC classification:
A61K 45/00; A61K 31/713; A61K 31/675; A61K 31/44; A61K 31/40;

Publication

European Patent Bulletin

Issue number:
202245
Publication date:
09/11/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
02/11/2026
Annual Fee Number:
11
Annual Fee Amount:
148 Euro
Expected Payer:
Last Annual Fee Payment Date:
16/10/2025
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
131 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
11/11/2022 Power Of Attorney 1
11/11/2022 Outgoing Correspondence 1